PEDIATRICS Vol. 102 No. 2 Supplement August 1998, pp. 501-506
Received Feb 6, 1998; accepted Mar 20, 1998.
From the Department of Pediatric Psychopharmacology, Massachusetts General Hospital, and the Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Stimulant-associated growth deficits in children with attention deficit hyperactivity disorder (ADHD) have long been a concern. Height deficits in preadolescence have been reported, but adult heights have been reported to be uncompromised. It is possible that the catch-up growth that occurs is related to ADHD-associated delayed maturation and not to the cessation of stimulant treatment. To date, no consistent neurohormonal pathophysiology to explain stimulant-associated height deficits has been identified nor have the initial associations of height and weight deficits been replicated. Attention deficit hyperactivity disorder is associated with dysregulation of several neurotransmitter systems, especially the catecholamines, that may alter neuroendocrine function and lead to growth delays. The literature on neuroendocrine aspects of growth and treatment in ADHD and on growth in boys with ADHD who are treated with psychotropics is reviewed, and the results of a controlled study in 124 boys with ADHD are presented. Small but significant differences in height were found between children with and without ADHD. However, the height deficits were evident in early, but not late, adolescence and were not related to the use of psychotropic medications. There was no evidence of weight deficits in children with ADHD relative to control subjects and no relationship between measures of malnutrition and short stature was found. These findings suggest that ADHD may be associated with temporary deficits in height gain through midadolescence that may normalize by late adolescence. This effect appears to be mediated by ADHD and not by its treatment.
Key words: attention deficit hyperactivity disorder, growth deficit, height deficit, weight deficit, stimulant.
This article has been cited by other articles:
![]() |
T. Hanc and J. Cieslik Growth in Stimulant-naive Children With Attention-Deficit/Hyperactivity Disorder Using Cross-sectional and Longitudinal Approaches Pediatrics, April 1, 2008; 121(4): e967 - e974. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Poulton Growth on stimulant medication; clarifying the confusion: a review Arch. Dis. Child., August 1, 2005; 90(8): 801 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Spencer, J. H. Newcorn, C. J. Kratochvil, D. Ruff, D. Michelson, and J. Biederman Effects of Atomoxetine on Growth After 2-Year Treatment Among Pediatric Patients With Attention-Deficit/Hyperactivity Disorder Pediatrics, July 1, 2005; 116(1): e74 - e80. [Abstract] [Full Text] [PDF] |
||||
![]() |
V A Harpin The effect of ADHD on the life of an individual, their family, and community from preschool to adult life Arch. Dis. Child., February 1, 2005; 90(suppl_1): i2 - i7. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. Sedlmeyer and M. R. Palmert Delayed Puberty: Analysis of a Large Case Series from an Academic Center J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1613 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Joshi and H. M. Adam ADHD, Growth Deficits, and Relationships to Psychostimulant Use Pediatr. Rev., February 1, 2002; 23(2): 67 - 68. [Full Text] [PDF] |
||||
![]() |
B. Vitiello Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder Can. Med. Assoc. J., November 1, 2001; 165(11): 1505 - 1506. [Full Text] [PDF] |
||||